108 related articles for article (PubMed ID: 16257566)
1. Role of anti-TGF-beta antibodies in the treatment of renal injury.
Gagliardini E; Benigni A
Cytokine Growth Factor Rev; 2006; 17(1-2):89-96. PubMed ID: 16257566
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of TGF-beta inhibition in chronic renal failure.
Gagliardini E; Benigni A
Expert Opin Biol Ther; 2007 Mar; 7(3):293-304. PubMed ID: 17309322
[TBL] [Abstract][Full Text] [Related]
3. [TGF-beta: usage in nephrology].
Quirin N; Feige JJ; Zaoui P
Nephrologie; 1996; 17(4):227-35. PubMed ID: 8768454
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
5. [The concept of nephroprotection: toward preventive and curative therapies for renal sclerosis].
Ronco P
J Soc Biol; 2002; 196(4):285-91. PubMed ID: 12645297
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ALK5 as a new approach to treat liver fibrotic diseases.
de Gouville AC; Huet S
Drug News Perspect; 2006 Mar; 19(2):85-90. PubMed ID: 16628263
[TBL] [Abstract][Full Text] [Related]
7. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
Langham RG; Kelly DJ; Gow RM; Zhang Y; Cordonnier DJ; Pinel N; Zaoui P; Gilbert RE
Diabetes Care; 2006 Dec; 29(12):2670-5. PubMed ID: 17130203
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
Russo LM; del Re E; Brown D; Lin HY
Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
[TBL] [Abstract][Full Text] [Related]
10. The soluble transforming growth factor-beta receptor: advantages and applications.
Russo LM; Brown D; Lin HY
Int J Biochem Cell Biol; 2009 Mar; 41(3):472-6. PubMed ID: 18339576
[TBL] [Abstract][Full Text] [Related]
11. [BMP-7 (Bone morphogenetic protein-7): a future treatment for chronic renal failure?].
Niksic L; Martin PY
Rev Med Suisse; 2005 Feb; 1(8):568-70, 572-3. PubMed ID: 15794307
[TBL] [Abstract][Full Text] [Related]
12. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
[TBL] [Abstract][Full Text] [Related]
13. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
Ziyadeh FN
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S38-41. PubMed ID: 18842317
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta signaling in vascular fibrosis.
Ruiz-Ortega M; Rodríguez-Vita J; Sanchez-Lopez E; Carvajal G; Egido J
Cardiovasc Res; 2007 May; 74(2):196-206. PubMed ID: 17376414
[TBL] [Abstract][Full Text] [Related]
15. Examining potential therapies targeting myocardial fibrosis through the inhibition of transforming growth factor-beta 1.
Khan R
Cardiology; 2007; 108(4):368-80. PubMed ID: 17308385
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease.
Mahajan D; Wang Y; Qin X; Wang Y; Zheng G; Wang YM; Alexander SI; Harris DC
J Am Soc Nephrol; 2006 Oct; 17(10):2731-41. PubMed ID: 16988067
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta in renal injury and disease.
Böttinger EP
Semin Nephrol; 2007 May; 27(3):309-20. PubMed ID: 17533008
[TBL] [Abstract][Full Text] [Related]
18. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta.
Yang YL; Chang SY; Teng HC; Liu YS; Lee TC; Chuang LY; Guh JY; Chang FR; Liao TN; Huang JS; Yeh JH; Chang WT; Hung MY; Wang CJ; Chiang TA; Hung CY; Hung TJ
J Cell Biochem; 2008 Jun; 104(3):908-19. PubMed ID: 18189272
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta (TGF-beta) and brain tumours.
Luwor RB; Kaye AH; Zhu HJ
J Clin Neurosci; 2008 Aug; 15(8):845-55. PubMed ID: 18550374
[TBL] [Abstract][Full Text] [Related]
20. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
